1 / 6Shares of Kotak mahindra bank rose nearly 2% on Friday after UBS upgraded the private lender to Buy from Neutral. UBS raised its price target to ₹2,450, implying a 26% potential upside from Thursday’s close. The brokerage highlighted Kotak’s diverse growth engines, including significant contributions from non-lending businesses such as asset management and insurance, which provide resilience compared with peers.
2 / 6Coforge received renewed optimism from Motilal Oswal, which reiterated its Buy rating with a price target of ₹2,240, suggesting nearly 29% potential upside. The brokerage pointed to Coforge’s robust executable order book and sustained client spending across verticals. It noted the company’s success in scaling large deals, with management targeting 20 deals above $20 million in FY26 (five closed so far). Coforge shares closed Friday at ₹1,726.00 (−0.64%) on NSE.
3 / 6Global brokerage CLSA reaffirmed its High Conviction Outperform rating on Avenue Supermartssetting a target of ₹6,406, a 36% potential upside from current levels. The brokerage underscored DMart’s winning edge in offering consistently lower prices, strong product assortment, and deep customer engagement. CLSA also noted that valuations do not fully capture the faster pace of store additions, growing private-label penetration, and strengthening profitability moat. Avenue Supermarts shares closed Friday at ₹4,752.00 (+1.11%) on NSE.
4 / 6Motilal Oswal initiated coverage on ER&D stocks, highlighting structural shifts reshaping mobility. It placed a Buy rating on KPIT Tech with a target price of ₹1,600, indicating 34% upside. The brokerage cited the accelerating shift towards CASE (connected, autonomous, shared, electric) mobility, software-defined vehicles, and global regulatory pushes for greener mobility as long-term drivers. Despite near-term moderation in OEM capex, the outlook for ER&D remains robust. KPIT Tech shares closed Friday at ₹1,189.00 (+0.39%) on NSE.
5 / 6Motilal Oswal reiterated its Buy on Petronet lng with a price target of ₹410, implying a potential upside of 50% from current levels. The brokerage said Petronet is strategically placed to benefit from India’s next LNG import growth cycle, aided by the upcoming 5 MMTPA capacity at Dahej, due by December 2025. Robust capacity growth and attractive valuations underpin the bullish view. Petronet LNG shares ended Friday at ₹271.00 (−0.22%) on NSE.
6 / 6Jefferies initiated coverage on Cohance Lifesciences with a Buy rating and a target price of ₹1,150, reflecting 30% potential upside. The brokerage believes Cohance is well-positioned to leverage industry tailwinds in Antibody Drug Conjugates (ADCs), supported by an integrated ADC platform, new customer wins, speciality chemicals diversification, and strong pipeline momentum. With big pharma diversifying to India, Cohance could capture significant growth across multiple segments. Cohance Lifesciences shares closed Friday at ₹874.50 (+0.33%) on NSE.
